Skip to main content
SpringerLink
Log in

Evaluation of risk for hepatitis B virus reactivation in patients with psoriasis treated with biologic therapies: a single-center retrospective study

  • RESEARCH LETTER
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

Data available upon request.

References

  1. Loomba R, Liang TJ (2017) Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions. Gastroenterology 152(6):1297–1309

    Article  PubMed  Google Scholar 

  2. Prussick RB, Miele L (2018) Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden? Br J Dermatol 179(1):16–29

    Article  CAS  PubMed  Google Scholar 

  3. Bath RK, Brar NK, Forouhar FA, Wu GY (2014) A review of methotrexate-associated hepatotoxicity. J Dig Dis 15(10):517–524

    Article  CAS  PubMed  Google Scholar 

  4. Fidan S, Capkin E, Arica DA, Durak S, Okatan IE (2021) Risk of hepatitis B reactivation in patients receiving anti-tumor necrosis factor-alpha therapy. Int J Rheum Dis 24(2):254–259

    Article  CAS  PubMed  Google Scholar 

  5. Caporali R, Bobbio-Pallavicini F, Atzeni F et al (2010) Safety of tumor necrosis factor alpha blockers in hepatitis B virus occult carriers (hepatitis B surface antigen negative/anti-hepatitis B core antigen positive) with rheumatic diseases. Arthritis Care Res (Hoboken) 62(6):749–754

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Dermatology and Venereology Clinic, Ankara Sincan Training and Research Hospital, Ankara, Turkey

    Gülsün Hazan Tabak

  2. Department of Dermatology and Venereology, School of Medicine, Hacettepe University, Ankara, Turkey

    Neslihan Akdoğan & Sibel Doğan Günaydın

  3. Department of Gastroenterology, School of Medicine, Hacettepe University, Ankara, Turkey

    Yavuz Emre Parlar, Hatice Yasemin Balaban & Halis Şimşek

Authors
  1. Gülsün Hazan Tabak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Neslihan Akdoğan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sibel Doğan Günaydın
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yavuz Emre Parlar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hatice Yasemin Balaban
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Halis Şimşek
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception and design. Data collection and analysis were performed by Gülsün Hazan Tabak. Gülsün Hazan Tabak wrote the main manuscript text, prepared figures, and drafted the manuscript; she is the study guarantor. All authors critically revised the manuscript.

Corresponding author

Correspondence to Gülsün Hazan Tabak.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest—financial or otherwise—related to the material presented herein.

Ethical approval

This study was approved by the Hacettepe University Non-Interventional Clinical Research Ethics Board (20.06.2022, GO 22/635). Informed consent form was not obtained due to the retrospective design of the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tabak, G.H., Akdoğan, N., Günaydın, S.D. et al. Evaluation of risk for hepatitis B virus reactivation in patients with psoriasis treated with biologic therapies: a single-center retrospective study. Arch Dermatol Res 316, 163 (2024). https://doi.org/10.1007/s00403-024-02918-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00403-024-02918-0

Search

Navigation